Previous 10 | Next 10 |
New York, New York--(Newsfile Corp. - June 27, 2022) - Levi & Korsinsky, LLP notifies investors in Inotiv, Inc. (NASDAQ: NOTV) ("Inotiv" or the "Company") of a class action securities lawsuit. The lawsuit on behalf of Inotiv investors has been commenced in the the United State...
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Inotiv, Inc. (“Inotiv” or the “Company”) (Nasdaq: NOTV) in the United States District Court for the Norther District of New Indi...
NEW YORK, NY / ACCESSWIRE / June 23, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inotiv, Inc. ("Inotiv" or the "Company") (NASDAQ:NOTV) and reminds investors of the August 22, 2022 deadline to seek the role of lead plai...
WEST LAFAYETTE, Ind., June 22, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and de...
Citing the recent challenges in the patient enrollment, the pharmacy chain operator Walgreens Boots Alliance (NASDAQ:WBA) announced the launch of its clinical trial business on Thursday to expedite the drug development process. Arguing that COVID-19 has exacerbated the difficulties in patient...
The following slide deck was published by Inotiv, Inc. in conjunction with this event. For further details see: Inotiv (NOTV) Investor Presentation - Slideshow
WEST LAFAYETTE, Ind., June 13, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and de...
Inotiv has largely focused on pre-clinical services that is performed prior to the initiation of any clinical trials in humans. NOTV’s revenue declined by 38% from 2011-2016 and EBITDA turned negative in 2016. Revenue has grown significantly from $20mm in FY ’16 to a...
Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The Headwaters Capital portfolio declined -10.9% compared to a -5.7% decline for the Russell Mid Cap index in Q1 2022. Similar to last year, I wil...
The law firm of Kirby McInerney LLP is investigating potential claims against Inotiv, Inc. (“Inotiv” or the “Company”) (NASDAQ: NOTV ). The investigation concerns whether Inotiv has violated the federal securities laws and/or engaged in other unlawful...
News, Short Squeeze, Breakout and More Instantly...
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela...